Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company ...

J.P. Morgan Asset Management Canada (JPMAM)* today announced the expansion of its actively managed exchange-traded funds (ETFs) with the launch of the JPMorgan Global Select Equity Active ETF (TSX: ...

The MEG Energy Corp. logo is seen ... weakness in Cenovus's stock, he said. Over the past year, Cenovus shares have fallen nearly 30 per cent to trade around the $20 mark. "It's kind of an interesting ...

The Toronto stock market climbed on Wednesday to a new record high, as Shopify took over as Canada's most valuable publicly ...

Canada's main stock index inched up on Friday as investors evaluated corporate results and U.S. President Donald Trump's ...

Fortis Inc. closed 0.4% short of its 52-week high of C$69.70, which the company achieved on August 1st.

Dollarama Inc. closed 1.7% short of its 52-week high of C$196.46, which the company achieved on June 11th.

TSX looks to rebound today after Thursday’s pullback, with firmer commodity prices, more earnings, and domestic jobs data in ...

The TSX looks to hold its record-setting momentum today as earnings from heavyweights like Restaurant Brands, BCE, Brookfield ...

Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

But investors don't buy them to beat the market. Over the past 30 years, Coca-Cola stock has seriously trailed the market, with a few moments of market-beating performance interspersed.